Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines

<div>Mortality risk (adjusted hazard ratio and 95% confidence intervals) of HIV infected patients after two months of antituberculosis therapy by CD4 lymphocyte counts, serum albumin, and age.</div>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines 

Figure 4 | Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines 